Suppr超能文献

在连续血糖监测设备使用欠佳的情况下,连续血糖监测指标达到具有代表性的血糖结果所需的最短采样持续时间。

Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use.

作者信息

Akturk Halis K, Sakamoto Casey, Vigers Tim, Shah Viral N, Pyle Laura

机构信息

Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.

出版信息

J Diabetes Sci Technol. 2025 Mar;19(2):345-351. doi: 10.1177/19322968231200901. Epub 2023 Sep 25.

Abstract

BACKGROUND

Two weeks of continuous glucose monitoring (CGM) sampling with >70% CGM use is recommended to accurately reflect 90 days of glycemic metrics. However, minimum sampling duration for CGM use <70% is not well studied. We investigated the minimum duration of CGM sampling required for each CGM metric to achieve representative glycemic outcomes for <70% CGM use over 90 days.

METHODS

Ninety days of CGM data were collected in 336 real-life CGM users with type 1 diabetes. CGM data were grouped in 5% increments of CGM use (45%-95%) over 90 days. For each CGM metric and each CGM use category, the correlation between the summary statistic calculated using each sampling period and all 90 days of data was determined using the squared value of the Spearmen correlation coefficient ().

RESULTS

For CGM use 45% to 95% over 90 days, minimum sampling period is 14 days for mean glucose, time in range (70-180 mg/dL), time >180 mg/dL, and time >250 mg/dL; 28 days for coefficient of variation, and 35 days for time <54 mg/dL. For time <70 mg/dL, 28 days is sufficient between 45 and 80% CGM use, while 21 days is required >80% CGM use.

CONCLUSION

We defined minimum sampling durations for all CGM metrics in suboptimal CGM use. CGM sampling of at least 14 days is required for >45% CGM use over 90 days to sufficiently reflect most of the CGM metrics. Assessment of hypoglycemia and coefficient of variation require a longer sampling period regardless of CGM use duration.

摘要

背景

建议进行两周的持续葡萄糖监测(CGM)采样,且CGM使用率>70%,以准确反映90天的血糖指标。然而,对于CGM使用率<70%时的最短采样持续时间研究不足。我们调查了在90天内CGM使用率<70%时,每种CGM指标实现代表性血糖结果所需的最短CGM采样持续时间。

方法

收集了336名1型糖尿病实际CGM使用者90天的CGM数据。CGM数据按90天内CGM使用率5%的增量分组(45%-95%)。对于每种CGM指标和每个CGM使用类别,使用斯皮尔曼相关系数()的平方值确定每个采样期计算的汇总统计量与所有90天数据之间的相关性。

结果

对于90天内CGM使用率为45%至95%的情况,平均血糖、血糖在目标范围内的时间(70-180mg/dL)、血糖>180mg/dL的时间以及血糖>250mg/dL的时间的最短采样期为14天;变异系数的最短采样期为28天,血糖<54mg/dL的时间的最短采样期为35天。对于血糖<70mg/dL,CGM使用率在45%至80%之间时28天就足够了,而CGM使用率>80%时需要21天。

结论

我们定义了次优CGM使用情况下所有CGM指标的最短采样持续时间。90天内CGM使用率>45%时,需要至少14天的CGM采样才能充分反映大多数CGM指标。无论CGM使用持续时间如何,低血糖评估和变异系数评估都需要更长的采样期。

相似文献

2
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.
Diabetes Technol Ther. 2024 Jul;26(7):503-508. doi: 10.1089/dia.2023.0476. Epub 2024 Feb 16.
4
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Diabetes Technol Ther. 2018 Apr;20(4):314-316. doi: 10.1089/dia.2017.0455. Epub 2018 Mar 22.
8
Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
Diabetes Technol Ther. 2024 Jun;26(6):394-402. doi: 10.1089/dia.2023.0513. Epub 2024 Apr 26.
9
Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.
Diabetes Technol Ther. 2023 Feb;25(2):140-142. doi: 10.1089/dia.2022.0401. Epub 2022 Dec 2.

本文引用的文献

1
Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
JAMA Netw Open. 2023 Feb 1;6(2):e230077. doi: 10.1001/jamanetworkopen.2023.0077.
3
International Consensus of Continuous Glucose Monitor Use in Pharmacological Clinical Trials in Diabetes.
Diabetes Technol Ther. 2023 Apr;25(4):217-218. doi: 10.1089/dia.2023.0054. Epub 2023 Feb 17.
4
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6.
5
Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.
Diabetes Technol Ther. 2023 Feb;25(2):140-142. doi: 10.1089/dia.2022.0401. Epub 2022 Dec 2.
6
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.
Diabetes Technol Ther. 2022 Oct;24(10):749-753. doi: 10.1089/dia.2022.0093. Epub 2022 Jun 27.
7
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. doi: 10.1177/19322968221085273. Epub 2022 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验